Cochrane South Africa, South African Medical Research Council, Cape Town, South Africa.
Cochrane South Africa, South African Medical Research Council, Cape Town, South Africa; Division of Epidemiology and Biostatistics, Department of Global Health, Faculty of Medicine and Health Sciences, Stellenbosch University, Stellenbosch, South Africa; Division of Epidemiology and Biostatistics, School of Public Health and Family Medicine, University of Cape Town, Cape Town, South Africa.
Vaccine. 2019 Oct 8;37(43):6317-6323. doi: 10.1016/j.vaccine.2019.09.019. Epub 2019 Sep 11.
On the 4 February 2019, the Western Cape Department of Health's Facebook page announced the implementation of a school-based vaccination campaign aimed to administer the first doses of human papillomavirus (HPV) vaccine in public schools to Grade 4 girls who are nine years old. This announcement was met with a flurry of social media responses posted on the campaign's Facebook page. This study identifies determinants of vaccine hesitancy amongst responses provided by social media users to this post. On 8 March 2019, we conducted a qualitative study including all 157 comments to the Facebook post. The post had 659 'emotion' reactions: 574 "likes", 62 "loves", 21 "angry faces", 2 "laughs", 2 "wows" and 1 "sad face". An overwhelming majority (636/659 i.e. 97%) of reactions were favourable to the HPV vaccination campaign. Out of the 157 comments, we judged 52 (33%) of them to be 'hesitant', suggesting that people with negative reactions though few in number, were more likely to be vocal deniers. Concern around the safety of HPV vaccines including effects on reproductive health was the most common theme identified. Other emerging themes included: risk of cervical cancer perceived as being low, issues around consent, concerns that girls are being used for research, questionable vaccine effectiveness, use of the school-based strategy for the campaign, risk-benefits calculations of HPV vaccination and constraints such as stock-outs. Knowing someone who had been affected or being at risk of cervical cancer, having knowledge about the causes of cervical cancer, confidence in the effectiveness and safety of the vaccine, knowing the vaccine was being used in high income settings, and having strong recommendations from the World Health Organisation and key actors seemed to increase the willingness to accept the vaccine. The magnitude and causes of HPV vaccine hesitancy need to be investigated to ensure the success of this programme.
2019 年 2 月 4 日,西开普省卫生部的 Facebook 页面宣布实施一项基于学校的疫苗接种运动,旨在向 9 岁的公立学校四年级女生接种首剂人乳头瘤病毒(HPV)疫苗。这一宣布在该运动的 Facebook 页面上引发了大量社交媒体回应。本研究确定了社交媒体用户对该帖子的回应中 HPV 疫苗犹豫的决定因素。2019 年 3 月 8 日,我们对包括该 Facebook 帖子的所有 157 条评论进行了定性研究。该帖子有 659 个“情绪”反应:574 个“赞”,62 个“爱”,21 个“愤怒的面孔”,2 个“笑”,2 个“哇”和 1 个“悲伤的面孔”。绝大多数(659 个中的 636 个,即 97%)的反应对 HPV 疫苗接种运动持肯定态度。在 157 条评论中,我们判断其中 52 条(33%)是“犹豫”的,这表明尽管人数很少,但对负面反应的人更有可能直言不讳地反对。对 HPV 疫苗安全性的担忧,包括对生殖健康的影响,是确定的最常见主题。其他新出现的主题包括:宫颈癌风险被认为很低,关于同意的问题,担心女孩被用于研究,对疫苗有效性的质疑,在学校开展运动的策略,HPV 疫苗接种的风险-效益计算,以及缺货等限制。知道有人受到影响或有患宫颈癌的风险,对宫颈癌的病因有了解,对疫苗的有效性和安全性有信心,知道疫苗在高收入环境中使用,并且得到世界卫生组织和主要行为者的强烈推荐,这些似乎都增加了接受疫苗的意愿。需要调查 HPV 疫苗犹豫的程度和原因,以确保该计划的成功。
Hum Vaccin Immunother. 2019-7-11
Br J Clin Pharmacol. 2025-6
Hum Vaccin Immunother. 2024-12-31
Medicine (Baltimore). 2024-6-14